Authors

• Y C Chen (ORCID: https://orcid.org/0009-0009-7173-0223)
• Ping Zhan (ORCID: https://orcid.org/0009-0001-3030-2662)
• Juan Ni (ORCID: https://orcid.org/0000-0003-3103-7095)
• Yanjun Du (ORCID: https://orcid.org/0000-0002-0762-9077)
• Dong Wang (ORCID: https://orcid.org/0000-0003-2475-0642)
• Yong Song (ORCID: https://orcid.org/0000-0002-3108-2307)
• Hedong Han
• Tangfeng Lv (ORCID: https://orcid.org/0009-0003-0987-6770)

Institutions

• Nanjing General Hospital of Nanjing Military Command (CN)
• Second Affiliated Hospital of Nanjing Medical University (CN)
• Nanjing Medical University (CN)
• Nanjing University (CN)

Publication Details

Journal

Therapeutic Advances in Medical Oncology

Published

2025-12-01

DOI

https://doi.org/10.1177/17588359251405044

Citations

1

Primary Topic

HER2/EGFR in Cancer Research

Type

article

Field-Weighted Citation Impact

1.05